Product
Freeze-dried human rabies vaccine (Vero cells) Chengda - 4-dose program
1 clinical trial
2 indications
Indication
Rabies Vaccine Adverse ReactionIndication
Safety and EfficacyClinical trial
A Randomized, Blinded, and Similar Vaccine-controlled Phase III Clinical Trial to Evaluate the Immunogenicity and Safety of the 5-dose Program and 4-dose (2-1-1) Program of Freeze-dried Human Rabies Vaccine (Vero Cells)Status: Active (not recruiting), Estimated PCD: 2024-09-30